Multi-center, Prospective, Randomized, Controlled Investigational Device Exemption Clinical Trial Comparing Mobi-C Cervical Artificial Disc to Anterior Discectomy and Fusion in the Treatment of Symptomatic Degenerative Disc Disease in the Cervical Spine
The International Journal of Spine Surgery2014Vol. 8, pp. 7–7
Citations Over TimeTop 10% of 2014 papers
Michael S. Hisey, Hyun W. Bae, Reginald J. Davis, Steven E. Gaede, Greg Hoffman, Kee Kim, Pierce D. Nunley, Daniel L. Peterson, Ralph F. Rashbaum, John Stokes
Abstract
This study adds to the literature supporting cervical TDR as a viable option to ACDF in appropriately selected patients with disc degeneration.
Related Papers
- → Five-year clinical results of cervical total disc replacement compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled, multicenter investigational device exemption clinical trial(2016)153 cited
- → Prospective, Randomized Comparison of One-level Mobi-C Cervical Total Disc Replacement vs. Anterior Cervical Discectomy and Fusion: Results at 5-year Follow-up(2016)130 cited
- → Multi-center, Prospective, Randomized, Controlled Investigational Device Exemption Clinical Trial Comparing Mobi-C Cervical Artificial Disc to Anterior Discectomy and Fusion in the Treatment of Symptomatic Degenerative Disc Disease in the Cervical Spine(2014)125 cited
- → Two-level total disc replacement with Mobi-C(r) over 3-years(2014)5 cited
- → Investigational Device Exemption Trial of Cervical Arthroplasty for Treatment of Degenerative Disc Disease at Two Levels: 24-Month Results of 330 Subjects(2012)1 cited